Compare SEV & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SEV | DRIO |
|---|---|---|
| Founded | 2019 | 2011 |
| Country | United States | United States |
| Employees | 46 | 165 |
| Industry | Auto Manufacturing | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 88.0M | 70.6M |
| IPO Year | 2025 | 2013 |
| Metric | SEV | DRIO |
|---|---|---|
| Price | $2.07 | $6.89 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $35.00 |
| AVG Volume (30 Days) | ★ 232.0K | 18.2K |
| Earning Date | 05-16-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 1559.02 |
| EPS | N/A | ★ 1.75 |
| Revenue | N/A | ★ $7,394,000.00 |
| Revenue This Year | N/A | $20.27 |
| Revenue Next Year | $17,757.14 | $47.58 |
| P/E Ratio | ★ N/A | $4.04 |
| Revenue Growth | N/A | ★ 43.02 |
| 52 Week Low | $1.29 | $5.84 |
| 52 Week High | $11.24 | $17.74 |
| Indicator | SEV | DRIO |
|---|---|---|
| Relative Strength Index (RSI) | 47.06 | 50.05 |
| Support Level | $1.97 | $6.23 |
| Resistance Level | $2.45 | $8.01 |
| Average True Range (ATR) | 0.12 | 0.39 |
| MACD | -0.03 | 0.02 |
| Stochastic Oscillator | 30.95 | 49.54 |
Aptera Motors Corp engages in the development, production, and distribution of energy efficient solar-powered, battery-electric vehicles. The company has designed the Aptera vehicle to provide up to an estimated 40 miles per day by collecting energy from the sun and storing it in its proprietary battery pack. The company operates as a single reportable segment focused on the development of solar electric vehicles.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. The company vertically integrated a health intelligence platform with a mission to power the behavior changes that drive greater health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, and AI built on that proprietary data. The company focuses on delivering user experiences, longer sustained engagement, and stronger clinical outcomes, at affordable prices, which then delivers the highest return on investment in the industry.